Column Group LLC - Q3 2022 holdings

$452 Million is the total value of Column Group LLC's 7 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .

 Value Shares↓ Weighting
NGM  NGM Biopharmaceuticals Inc$237,228,000
+2.0%
18,136,7350.0%52.50%
+6.1%
RVMD BuyRevolution Medicines Inc$90,275,000
+5.4%
4,577,840
+4.2%
19.98%
+9.6%
RAPT  RAPT Therapeutics Inc$64,492,000
+31.8%
2,680,4580.0%14.27%
+37.1%
 Tenaya Therapeutics, Inc.$27,261,000
-48.5%
9,400,2900.0%6.03%
-46.4%
 Surrozen, Inc.$18,681,000
-32.7%
9,248,1290.0%4.14%
-30.0%
ORIC  ORIC Pharmaceuticals Inc.$11,418,000
-28.6%
3,568,1810.0%2.53%
-25.7%
 eFFECTOR Therapeutics Inc$2,465,000
-59.7%
4,309,3290.0%0.55%
-58.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NGM Biopharmaceuticals Inc12Q3 202352.5%
Revolution Medicines Inc12Q3 202336.3%
RAPT Therapeutics Inc12Q3 202329.6%
ORIC Pharmaceuticals Inc.12Q3 202314.6%
Tenaya Therapeutics, Inc.9Q3 202324.2%
Surrozen, Inc.9Q3 20238.2%
eFFECTOR Therapeutics Inc9Q3 20236.9%
Constellation Pharmaceuticals Inc.3Q2 202112.6%
Nurix Therapeutics Inc2Q1 202116.1%
Gritstone Oncology Inc1Q4 20200.3%

View Column Group LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-13
13F-HR2023-07-24
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
42022-05-27
42022-05-25
13F-HR2022-05-16

View Column Group LLC's complete filings history.

Compare quarters

Export Column Group LLC's holdings